Immatics IMTX
NASDAQ IMTX
$9.56 +0.10 (+1.06%)
As of: Sep 4, 2026 · 3:59 PM EDT

Immatics (IMTX) Change in Acquisitions & Divestments (2022 - 2026)

Immatics (IMTX) posted Change in Acquisitions & Divestments of $34.7 million for Q4 2025, down 76.04% sequentially from $144.7 million in Q3 2025, and down 32.55% YoY from $51.4 million in Q4 2024.

Analysis

Immatics (IMTX) Change in Acquisitions & Divestments (2022 - 2026) Analysis & Trends

Immatics has reported Change in Acquisitions & Divestments for 4 years, with the latest figure at $34.7 million in Q4 2025.

  • Quarterly Change in Acquisitions & Divestments fell 32.55% year-over-year to $34.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $603.3 million (up 77.29% YoY) and the FY2025 annual result came in at $621.2 million, up 82.54% from the prior year.
  • Change in Acquisitions & Divestments fell to $34.7 million in Q4 2025 per IMTX's latest filing, from $144.7 million in the prior quarter.
  • Over five years, Change in Acquisitions & Divestments peaked at $324.5 million in Q1 2025 and troughed at -$246.5 million in Q4 2023.
  • A 4-year average of $68.6 million and a median of $71.9 million in 2023 frame the typical range for Change in Acquisitions & Divestments.
  • The sharpest annual moves came in 2023 and 2025: Change in Acquisitions & Divestments surged 1628.65% in 2023, then sank 33.4% in 2025.
  • Over 4 years, Change in Acquisitions & Divestments stood at $6.1 million in 2022, then sank by 4152.08% to -$246.5 million in 2023, then soared by 120.84% to $51.4 million in 2024, then sank by 32.55% to $34.7 million in 2025.
  • According to Business Quant data, Change in Acquisitions & Divestments over the past three periods registered $34.7 million, $144.7 million, and $99.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Immatics 1.17 Bn 711.21 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 73.01 Mn
Mar 31, 2026 50.02 Mn
Dec 31, 2025 34.65 Mn
Sep 30, 2025 144.65 Mn
Jun 30, 2025 99.40 Mn
Mar 31, 2025 324.55 Mn
Dec 31, 2024 51.38 Mn
Sep 30, 2024 76.67 Mn
Jun 30, 2024 149.25 Mn
Mar 31, 2024 62.96 Mn
Dec 31, 2023 199.25 Mn
Sep 30, 2023 70.35 Mn
Jun 30, 2023 105.18 Mn
Mar 31, 2023 73.35 Mn
Jun 30, 2022 6.08 Mn
Mar 31, 2022 7.85 Mn